Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins

H. Wulf Johansson, M. Thinggaard, Q. Tan, K. Christensen, U. Holmskov, G. Lykke Sørensen (Odense, Denmark)

Source: Annual Congress 2011 - Lung cell biology
Session: Lung cell biology
Session type: Thematic Poster Session
Number: 764
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Wulf Johansson, M. Thinggaard, Q. Tan, K. Christensen, U. Holmskov, G. Lykke Sørensen (Odense, Denmark). Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins. Eur Respir J 2011; 38: Suppl. 55, 764

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late-breaking abstract: Association between serum surfactant protein D (SP-D) and lung function measurements in self-reported healthy twins
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011

Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014


Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP)
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD
Source: International Congress 2014 – Predictors
Year: 2014

Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007


Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Serum immunoglobulin E (IgE) in COPD: analysis of the German COSYCONET cohort
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Lower respiratory illness (LRI) in very preterm infants: results from the Italian area-based "action" cohort
Source: Annual Congress 2009 - From birth to adulthood - lifecourse determinants of asthma
Year: 2009


Vitamin D levels and risk of infection, assessment for disease severity, and predictor of mortality in the Chinese intensive care units: A prospective cohort study
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012

Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014

Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation
Source: Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017
Year: 2017



Calprotectin – A marker of mortality in COPD? Results from a prospective cohort study
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012


Association between asthma and lung function in adolescents born very preterm: results of the EPIPAGE cohort study.
Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing
Year: 2018


Undiagnosed COPD: who is at risk, and does it matter? The Guangzhou biobank cohort study (GBCS)
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009


Age-specific effects of NPSR1 and DPP10 in asthma and atopy: an international population-based cohort study (ECRHS)
Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms
Year: 2009